Canale-Theakston Carin has filed 10 insider transactions across 1 company since July 2024.
Most recent transaction: a disposition of 11100 shares of Cidara Therapeutics, Inc. ($CDTX) on January 07, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | Canale-Theakston Carin | Director | D | Stock Option (right to buy) | 11100 | $0.00 | 0.0000 | 31,439,371 | 100.00% | 0.04% |
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | Canale-Theakston Carin | Director | D | Stock Option (right to buy) | 2125 | $0.00 | 0.0000 | 31,439,371 | 100.00% | 0.01% |
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | Canale-Theakston Carin | Director | D | Stock Option (right to buy) | 2125 | $0.00 | 0.0000 | 31,439,371 | 100.00% | 0.01% |
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | Canale-Theakston Carin | Director | D | Stock Option (right to buy) | 16000 | $0.00 | 0.0000 | 31,439,371 | 100.00% | 0.05% |
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | Canale-Theakston Carin | Director | D | Stock Option (right to buy) | 1750 | $0.00 | 0.0000 | 31,439,371 | 100.00% | 0.01% |
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | Canale-Theakston Carin | Director | D | Stock Option (right to buy) | 875 | $0.00 | 0.0000 | 31,439,371 | 100.00% | 0.00% |
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | Canale-Theakston Carin | Director | D | Stock Option (right to buy) | 1400 | $0.00 | 0.0000 | 31,439,371 | 100.00% | 0.00% |
| June 18, 2025 | Cidara Therapeutics, Inc. | $CDTX | Canale-Theakston Carin | Director | A | Stock Option (right to buy) | 11100 | $0.00 | 11,100.0000 | 10,953,490 | 9999.99% | 0.10% |
| Dec. 17, 2024 | Cidara Therapeutics, Inc. | $CDTX | Canale-Theakston Carin | Director | A | Stock Option (right to buy) | 16000 | $0.00 | 16,000.0000 | 0 | 9999.99% | 0.00% |
| July 18, 2024 | Cidara Therapeutics, Inc. | $CDTX | Canale-Theakston Carin | Director | A | Stock Option (right to buy) | 2125 | $0.00 | 2,125.0000 | 0 | 9999.99% | 0.00% |